240 related articles for article (PubMed ID: 1684908)
1. Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells.
Ido M; Nagao Y; Higashigawa M; Shibata T; Taniguchi K; Hamazaki M; Sakurai M
Br J Cancer; 1991 Dec; 64(6):1103-7. PubMed ID: 1684908
[TBL] [Abstract][Full Text] [Related]
2. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
[TBL] [Abstract][Full Text] [Related]
3. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
[TBL] [Abstract][Full Text] [Related]
5. Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides.
Hagiwara M; Wakusawa S; Miyamoto K; Hidaka H
Cancer Lett; 1991 Nov; 60(2):103-7. PubMed ID: 1682033
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
[TBL] [Abstract][Full Text] [Related]
7. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H
Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896
[TBL] [Abstract][Full Text] [Related]
8. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
[TBL] [Abstract][Full Text] [Related]
9. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
[TBL] [Abstract][Full Text] [Related]
10. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein.
Staats J; Marquardt D; Center MS
J Biol Chem; 1990 Mar; 265(7):4084-90. PubMed ID: 1968066
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine(H-7) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemic cell.
Ido M; Asao T; Sakurai M; Inagaki M; Saito M; Hidaka H
Leuk Res; 1986; 10(9):1063-9. PubMed ID: 3762216
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
14. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
Higashigawa M; Ido M; Nagao Y; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M
Leuk Res; 1991; 15(8):675-81. PubMed ID: 1895749
[TBL] [Abstract][Full Text] [Related]
15. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
